Biogen amends bylaws to change 'Chairman' title to 'Chair'

BIOGEN INC.

Board approved Fourth Amended and Restated Bylaws effective April 12, 2023.
Title change from 'Chairman' to 'Chair' adopted in corporate governance documents.
No impact on financial position, operations, or leadership roles beyond nomenclature.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

BIOGEN INC.: Effective April 12, 2023, the Board approved amended bylaws to change the title of 'Chairman' to 'Chair' (effective 2023-04-12).

Change: bylaw amendment
Effective: 2023-04-12

Exact text from the filing

Effective April 12, 2023, the Board of Directors of Biogen Inc. (the “Company”) approved the Company’s Fourth Amended and Restated Bylaws, as amended through April 12, 2023 (as so amended, the “Amended Bylaws”), to change the title of “Chairman” to “Chair.”

View on SEC.gov

Browse all governance changes →

BIOGEN INC. filing history →

Source: SEC EDGAR

accession 0001193125-23-105074

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.